-
261
Global stability for a mosquito-borne disease model with continuous-time age structure in the susceptible and relapsed host classes
Published 2024-11-01Subjects: “…mosquito-borne infectious diseases…”
Get full text
Article -
262
-
263
Current status of recombinant duck enteritis virus vector vaccine research
Published 2025-02-01Subjects: Get full text
Article -
264
MANAGEMENT OF A RARE CASE OF PEDIATRIC DEEP STERNAL WOUND INFECTION WITH VACUUM-ASSISTED CLOSURE (VAC)
Published 2022-12-01Subjects: Get full text
Article -
265
Health security—Why is ‘public health’ not enough?
Published 2025-01-01Subjects: Get full text
Article -
266
-
267
A transdisciplinary approach to combatting the threat of African swine fever in Philippine Endemic Pigs
Published 2024-12-01Subjects: Get full text
Article -
268
Characteristics of participants in a public rubella antibody testing program conducted at a Japan professional football league venue
Published 2023-05-01Subjects: Get full text
Article -
269
The Use of Antiviral Drugs for Influenza: Recommended Guidelines for Practitioners
Published 2006-01-01“…Canadian Journal of Infectious Diseases and Medical Microbiology…”
Get full text
Article -
270
Hantavirus and Leptospira are important causes of nonspecific acute febrile syndrome, Meta, Colombia
Published 2025-03-01Subjects: “…Emerging infectious diseases…”
Get full text
Article -
271
Presentation and Outcome of Infection in Hospitalized Patients with Diabetic Foot at a Tertiary Care Hospital
Published 2024-04-01Subjects: Get full text
Article -
272
Variability of microbiomes in winter rye, wheat, and triticale affected by snow mold: predicting promising microorganisms for the disease control
Published 2025-01-01Subjects: Get full text
Article -
273
An Active-Learning Framework for Educating Medical Students on SARS-CoV-2 Variants and COVID-19 Epidemiology [version 1; peer review: 2 approved]
Published 2024-11-01Subjects: Get full text
Article -
274
-
275
Prevention and control of nosocomial infection in a certain endoscopy center under the management of COVID-19 with measures against Class B infectious diseases (新型冠状病毒感染“乙类乙管”下内窥镜中心感染防控与实践)
Published 2023-10-01“…Under the management of COVID-19 with measures against Class B infectious diseases, efforts should be made to enhance the emergency management and implementation of preoperative screening, therapeutic indications and diagnosis condition for digestive endoscopy. …”
Get full text
Article -
276
Mpox in sports: A comprehensive framework for anticipatory planning and risk mitigation in football based on lessons from COVID-19
Published 2024-10-01Subjects: Get full text
Article -
277
The autoimmune disease risk variant NCF1-His90 is associated with a reduced risk of tuberculosis in women
Published 2025-01-01Subjects: Get full text
Article -
278
Lyapunov functions and global stability for SIR and SEIR models withage-dependent susceptibility
Published 2012-12-01Subjects: Get full text
Article -
279
Respiratory syncytial virus vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine
Published 2025-12-01“…Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection, hospitalisation and death in adults.Methods Based on evidence regarding the impact of RSV on adult populations at risk for severe infection and the efficacy and safety of RSV vaccines, the Portuguese Society of Pulmonology, the Portuguese Association of General and Family Medicine, the Portuguese Society of Cardiology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Endocrinology, Diabetes and Metabolism, and the Portuguese Society of Internal Medicine endorses this position paper with recommendations to prevent RSV-associated disease and its complications in adults through vaccination.Conclusion The RSV vaccine is recommended for people aged ≥50 years with risk factors (chronic obstructive pulmonary disease, asthma, heart failure, coronary artery disease, diabetes, chronic kidney disease, chronic liver disease, immunocompromise, frailty, dementia, and residence in a nursing home) and all persons aged ≥60 years. …”
Get full text
Article -
280
An analytical cross-sectional study on optimal (timely or cumulative age-appropriate) routine childhood immunization coverage in the communities of Ebonyi state, Nigeria
Published 2025-01-01Subjects: “…Vaccine-preventable infectious diseases…”
Get full text
Article